Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Stocks

DexCom Stock Rises From the Ashes: A Breakout You Can’t Ignore

by admin January 18, 2025
January 18, 2025
DexCom Stock Rises From the Ashes: A Breakout You Can’t Ignore

As advancements in medical technology continue to shape the healthcare landscape, DexCom, Inc. (DXCM) stands out with its innovative continuous glucose monitoring solutions. Recent price action suggests that DXCM’s stock price has triggered a potentially new bullish run. In this article, I will examine the technical and fundamental factors behind this positive outlook and outline a risk-defined options strategy — all identified via the OptionsPlay Strategy Center within StockCharts.com.

After consolidating between $75 and $80 over the past two months, DXCM’s stock price recently broke out of this trading range with impressive relative strength.

  • Range Breakout. The stock’s breakout above $80 marks a decisive breakout from its consolidation zone.
  • Outperformance. The breakout has been coupled with outperformance to the S&P 500.
  • Upside Target. Given the breakout, there is potential for DXCM’s stock price to fill the gap up to the $107.50 level.

FIGURE 1. DAILY CHART OF DXCM STOCK. The stock price traded between $75 and $80 since the end of November. DXCM recently broke out of its consolidation zone and traded above $80.Chart source: StockCharts.com. For educational purposes.

Beyond the charts, DXCM’s fundamentals support its premium valuation:

  • Premium but justified. While trading at 39x forward earnings, DXCM’s superior growth expectations and higher net margins than peers suggest that this valuation is justified.
  • Potential for substantial upside. Robust demand in the continuous glucose monitoring market and DexCom’s leadership position the company to capitalize on ongoing trends. The combination of strong growth prospects and healthy margins provides the potential for further appreciation.

Options Strategy

Based on this bullish thesis, the OptionsPlay Strategy Center highlights a bull put spread.

  • Sell: February 28, 2025, $84 Put at $5.40
  • Buy: February 28, 2025, $77 Put at $2.42
  • Net Credit: $2.98 per share (or $298 total per contract, since each contract represents 100 shares)

FIGURE 2. DXCM BULL PUT SPREAD RISK CURVE.

Trade Details

  • Maximum Potential Reward: $298
  • Maximum Potential Risk: $402
  • Breakeven Point: $81.02
  • Probability of Profit: 58.58%

This strategy benefits from time decay and a bullish outlook, providing limited risk and a defined reward. At expiration, profits are earned if DXCM’s stock price remains above the breakeven level.

Unlock Real-Time Trade Ideas

This bullish trade in DXCM was identified using the OptionsPlay Strategy Center within StockCharts.com. The platform’s Bullish Outperform scan (see below) automatically flagged DXCM as the best candidate for selling a Bull Put Spread out of the many stocks currently outperforming the market, then structured the optimal options trade — helping you save hours of research.

FIGURE 3. BULLISH OUTPERFORMANCE SCAN. DXCM was identified as a candidate for a bull put spread.


By subscribing to the OptionsPlay Strategy Center, you gain access to:

  •  Automated Market Scans. Quickly discover high-probability trading opportunities based on technical and fundamental signals.
  • Optimal Trade Structuring. Receive tailored, real-time options strategies for your market outlook and risk tolerance.
  • Time-Saving Insights. Make informed decisions faster, avoiding the time-consuming process of manual analysis.

Don’t miss out on your next high-conviction idea. Subscribe to the OptionsPlay Strategy Center today and unlock a streamlined approach to uncovering the best options trades—all within seconds, every single day. Let OptionsPlay be your strategic ally in navigating the markets efficiently and effectively.

0
FacebookTwitterGoogle +Pinterest
previous post
Treasury Department recoups $31 million in improper government payments to dead people
next post
Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports

Related Posts

Retail is at a Crossroads—Buy Now or Stay...

February 28, 2025

Bearish ADX Signal on S&P Plays Out –...

March 14, 2025

Week Ahead: NIFTY’s Behavior Against This Level To...

December 22, 2024

Can the S&P 500 Rally Without Tech?

November 29, 2024

S&P 500 Sectors Play Musical Chairs: How To...

February 10, 2025

Relative Strength Screams Bullish for This Tech Stock

May 11, 2024

How to Use Fibonacci Retracements to Spot Key...

June 25, 2025

The Real Drivers of This Market: AI, Semis...

July 20, 2025

Gold Top? Focus on These Potential Price Objectives

June 18, 2024

How to Use Relative Strength in a Volatile...

May 15, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • Sydney Sweeney jeans controversy making advertising great again

      August 10, 2025
    • Nagasaki mayor issues chilling warning on 80th anniversary of atomic bombing

      August 10, 2025
    • Kash Patel celebrates major FBI achievements and record seizures during Trump’s first 200 days in office

      August 10, 2025
    • Trump nominates State Department spokeswoman Tammy Bruce as UN deputy representative

      August 10, 2025
    • White House responds to surge in Christian persecution crisis across sub-Saharan Africa

      August 10, 2025

    Categories

    • Business (1,058)
    • Investing (2,793)
    • Politics (3,438)
    • Stocks (1,155)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved